P-Value Workshop
19 Dec 2025
Brussels, 19 December 2025
On 9 December, EORTC hosted the second P-value Workshop, and welcomed over 250 participants online from over 43 countries.
The workshop, marking 100 years of the 5% p-value cutoff, was a great opportunity to exchange views on how we define scientific evidence today. Discussions highlighted the continued relevance of p-values, while also emphasising the need to avoid relying on them in isolation.
Speakers and participants explored how decision-making in clinical research should be informed by a balanced assessment of benefits and risks, supported by reliable estimates, and how future guidelines could help shape a more nuanced and meaningful approach to evidence-based research.
The discussions were insightful and engaging. A big thank you to our speakers for their valuable contributions, and to everyone who joined and shared their perspectives. A full report will be shared in due course capturing the key insights from these conversations.
Related News
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
Long-term EORTC trial challenges assumptions about lymph node radiation therapy in breast cancer
17 May 2026
Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma
1 May 2026
EORTC’s presence at ESTRO 2026
30 Apr 2026
